vTv Therapeutics Inc. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- vTv Therapeutics Inc. stock issued during period, value, stock options exercised for the quarter ending 2025-12-31 was $7.00K.
- vTv Therapeutics Inc. stock issued during period, value, stock options exercised for the quarter ending 2025-09-30 was $0.00.
- vTv Therapeutics Inc. stock issued during period, value, stock options exercised for the quarter ending 2025-06-30 was $9.00K.
- vTv Therapeutics Inc. stock issued during period, value, stock options exercised for the quarter ending 2021-12-31 was $0.00.
- vTv Therapeutics Inc. stock issued during period, value, stock options exercised for fiscal 2025 was $16.00K.
- vTv Therapeutics Inc. stock issued during period, value, stock options exercised for fiscal 2021 was $47.00K.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2025-12-31 | $7.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $16.00K 10-K · filed 2026-03-10 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | |
| 2025-06-30 | $9.00K 10-Q · filed 2026-08-06 | |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | $47.00K 10-K · filed 2024-03-13 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | |
| 2021-06-30 | $47.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | |
| 2021-03-31 | $0.00 10-Q · filed 2022-05-12 |